Determination of binding kinetics is an imperative and laborious phase in biological drug discovery. The WAVEsystem, a Creoptix technology, was developed with researchers in mind. Based on the GCI detection principle, it provides outstanding sensitivity, reducing sample consumption and mass transfer hindrances.
Combining GCI technology with our no-clog WAVEchips and waveRAPID (a new method of measuring kinetics from single concentration), the WAVEsystem will increase your throughput and optimize your workflow.
What will you learn?
Determination of binding kinetics is an imperative and laborious phase in biological drug discovery. The WAVEsystem, a Creoptix technology, was developed with researchers in mind. Based on the GCI detection principle, it provides outstanding sensitivity, reducing sample consumption and mass transfer hindrances.
Combining GCI technology with our no-clog WAVEchips and waveRAPID (a new method of measuring kinetics from single concentration), the WAVEsystem will increase your throughput and optimize your workflow.
What will you learn?